
Midatech Pharma plc MTP
Annual report 2024
added 02-21-2026
Midatech Pharma plc Shares 2011-2026 | MTP
Annual Shares Midatech Pharma plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 80.5 M | 9.16 K | 9.16 K | 620 K | 521 K | 366 K | 285 K | - | - | - | - |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 80.5 M | 9.16 K | 11.8 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M | ||
|
Alector
ALEC
|
103 M | $ 2.11 | -13.17 % | $ 217 M | ||
|
Acer Therapeutics
ACER
|
15.8 M | - | 2.71 % | $ 14 M | ||
|
Axsome Therapeutics
AXSM
|
49.7 M | $ 163.89 | - | $ 8.15 B | ||
|
BridgeBio Pharma
BBIO
|
192 M | $ 64.28 | -3.31 % | $ 12.3 B | ||
|
I-Mab
IMAB
|
187 M | - | - | $ 866 M | ||
|
BioCardia
BCDA
|
21.2 M | $ 1.37 | 5.81 % | $ 29 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
1.08 K | - | -10.17 % | $ 12.2 K | ||
|
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | ||
|
BioLineRx Ltd.
BLRX
|
663 M | $ 2.82 | -0.35 % | $ 908 M | ||
|
BioMarin Pharmaceutical
BMRN
|
192 M | $ 59.8 | -3.13 % | $ 11.5 B | ||
|
Bristol-Myers Squibb Company
BMY
|
2.03 B | $ 62.08 | -0.46 % | $ 126 B | ||
|
Benitec Biopharma
BNTC
|
41.2 M | $ 10.93 | 0.23 % | $ 450 M | ||
|
BioNTech SE
BNTX
|
244 M | $ 109.33 | -0.82 % | $ 27.2 B | ||
|
Black Diamond Therapeutics
BDTX
|
55 M | $ 2.38 | -3.44 % | $ 131 M | ||
|
ARCA biopharma
ABIO
|
16.8 M | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | ||
|
BioXcel Therapeutics
BTAI
|
2.54 M | $ 1.63 | -2.4 % | $ 4.13 M | ||
|
Acasti Pharma
ACST
|
12.1 M | - | 4.01 % | $ 150 M | ||
|
Burford Capital Limited
BUR
|
219 M | $ 8.65 | 2.49 % | $ 1.39 B | ||
|
Adverum Biotechnologies
ADVM
|
19.8 M | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - | ||
|
AIkido Pharma
AIKI
|
6.18 M | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | ||
|
BeyondSpring
BYSI
|
40.3 M | $ 1.34 | -0.87 % | $ 54 M | ||
|
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | ||
|
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M | ||
|
Cabaletta Bio
CABA
|
1.17 M | $ 3.34 | 0.61 % | $ 3.9 M | ||
|
Aileron Therapeutics
ALRN
|
17.9 M | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
5.01 M | - | 4.14 % | $ 49.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.18 B | $ 4.88 | 2.74 % | $ 10.6 B | ||
|
Alpine Immune Sciences
ALPN
|
33.4 M | - | - | $ 2.17 B | ||
|
Capricor Therapeutics
CAPR
|
26.8 M | $ 27.28 | -2.32 % | $ 731 M | ||
|
Aeterna Zentaris
AEZS
|
115 M | - | 5.93 % | $ 314 M | ||
|
Ampio Pharmaceuticals
AMPE
|
810 K | - | -11.43 % | $ 502 K | ||
|
Catalyst Biosciences
CBIO
|
65.8 M | $ 11.67 | -3.47 % | $ 768 M | ||
|
Applied Molecular Transport
AMTI
|
38.8 M | - | - | $ 10.1 M | ||
|
Aravive
ARAV
|
36.4 M | - | -13.39 % | $ 1.45 M | ||
|
C4 Therapeutics
CCCC
|
82.9 M | $ 3.06 | 13.3 % | $ 254 M | ||
|
Aptose Biosciences
APTO
|
699 K | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
67.7 M | - | -39.0 % | $ 4.57 M | ||
|
Athira Pharma
ATHA
|
38.5 M | - | - | $ 269 M | ||
|
Codexis
CDXS
|
73.4 M | $ 0.99 | -2.04 % | $ 72.7 M | ||
|
Aridis Pharmaceuticals
ARDS
|
18.8 M | - | 17.91 % | $ 11.1 M |